Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7130892

Cn1ccc2c1C([Zr+2]c1cccc3c1Cc1ccccc1-3)c1ccccc1-2.[Cl-].[Cl-]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.35
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HTR7 P34969 1/20 0.30
HTR2B P41595 1/20 0.30
HTR2A P28223 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7121843 0.78 PNMT (0.33) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL7119556 0.74 GPR3 (0.36)
Hydrochloric Acid SCHEMBL7119329 0.73 GSK3A (0.31) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL7124880 0.73 PNMT (0.32) PNMT
Hydrochloric Acid SCHEMBL7265194 0.72 PNMT (0.35) PNMTNPC1RAB9A
SCHEMBL7130890 0.71 PNMT (0.32) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL7129107 0.71
Hydrochloric Acid SCHEMBL5392297 0.70 PNMT (0.32) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL5380067 0.70 PNMT (0.33) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL7272255 0.69 PNMT (0.36) PNMTNPC1RAB9AHTR7HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030148877-A1 Metallocenes and catalysts for olefin-polymerisation BASELL TECHNOLOGY COMPANY BV (NL) 2003-08-07 US disclosed
EP-0952978-B1 METALLOCENES AND CATALYSTS FOR OLEFIN-POLYMERISATION BASELL POLYOLEFINE GMBH (DE) 2003-01-22 EP disclosed
EP-0952978-A1 METALLOCENES AND CATALYSTS FOR OLEFIN-POLYMERISATION Montell Technology Company bv (NL) 1999-11-03 EP disclosed
WO-1999024446-A1 METALLOCENES AND CATALYSTS FOR OLEFIN-POLYMERISATION MONTELL TECHNOLOGY COMPANY B.V. (NL) 1999-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030148877-A1 Metallocenes and catalysts for olefin-polymerisation MT-CO1, CPNE4, MT-CO3 PNMT 259/4885NPC1 2068/4885RAB9A 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.